News | September 07, 2008

First Procedures Performed With Re-introduced Stereotaxis Magnetic Irrigated Catheter

September 8, 2008 - Stereotaxis Inc. said today the first atrial fibrillation procedures using its re-introduced partnered magnetic irrigated catheter were successfully performed in Europe last week.

The catheter received CE mark approval in the last week of August following its resubmission to European regulators by the company’s partner in July 2008, and these first cases are part of the standard pre-release evaluation.

In July, the company’s partner submitted a PMA Supplement FDA for use of the magnetic catheter in the U.S. with the expectation that U.S. approval would be obtained subsequent to the European CE mark.

“I am delighted with the results of my first procedures performed successfully with the newly available Biosense magnetic irrigated catheter,” said Carlo Pappone, M.D, Ph.D., FACC, who performed the first procedures last week at San Raffaele University Hospital in Milan, Italy. “I am extremely happy with its performance, and believe that Biosense did an excellent job. Contact stability, lesion quality and overall mechanical performance are excellent, and I believe safety is likely to be exemplary.”

The catheter is used primarily for complex procedures in the left atrium of the heart.

For more information: www.stereotaxis.com

Related Content

Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
Philips Announces Relaunch of Pioneer Plus IVUS-Guided Catheter
News | Chronic Total Occlusion (CTO)| June 28, 2017
June 28, 2017 — Royal Philips recently announced the relaunch of its Pioneer Plus...
Sponsored Content | Videos | Angiography| June 22, 2017
Shimadzu Medical Systems highlighted new features of its Trinias Interventional X-ray line at the America College of
3d printing can aid procedural navigation in transcatheter tricuspid procedures
News | 3-D Printing| June 15, 2017
June 15, 2017 – Structural heart interventions are increasingly applied in patients with severe tricuspid regurgitati
Sponsored Content | Videos | Cardiovascular Ultrasound| June 15, 2017
Madhav Swaminathan, M.D., FASC, FAHA, clinical director of cardiothoracic anesthesiology, at Duke Univer
iFR, iFR vs. FFR, ACC late breaking trial, iFR-SWEDEHEART, DEFINE-FLAIR, Justin E. Davies,

Matthias Götberg, principal investigator for the iFR-SWEDEHEART study, and Justin E. Davies, lead investigator for the DEFINE-FLAIR trial, share key points of their study with DAIC editor Dave Fornell at ACC.17. The trials showed iFR is equal in outcomes to FFR in assessing coronary lesions. 

Feature | FFR Catheters| March 20, 2017
March 20, 2017 — For patients experiencing angina (chest pain) or a heart attack, instantaneous wave-free ratio (iFR)
Sponsored Content | Videos | HIMSS| March 10, 2017
ITN Editor Dave Fornell takes a tour of some of the most innovative new technology that was displayed on the expo flo
interventional cardiology, cath lab videos
Feature | Cath Lab| March 07, 2017
Here is a compilation of some of DAIC's recent video coverage of new interventional cardiology device techno
Teleflex, FDA 510k clearance, TrapLiner Catheter, U.S. launch
Technology | Catheters| March 02, 2017
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
Overlay Init